Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new two-year project funded by the UK Department for International Development (DFID) will strengthen training and delivery capacity for clubfoot treatment in sub-Saharan Africa.

Around 200,000 children born each year are affected by clubfoot, with 80% of these in low and middle income countries. Without treatment, the condition becomes ‘neglected clubfoot’, a painful and severely disabling deformity. However, in up to 95% of cases, clubfoot can be treated successfully using the Ponseti method of treatment, especially if this is initiated early.

A new two-year project funded by the UK Department for International Development (DFID) will strengthen training and delivery capacity for clubfoot treatment in sub-Saharan Africa. Starting in March 2015, the Africa Clubfoot Training (ACT) Project will support existing clubfoot treatment programmes through training a new cadre of national clubfoot trainers in 15 countries.

The ACT Project aims to strengthen partnerships between clubfoot service delivery partners within Ethiopia and across the region. A team of UK NHS, Ethiopian and regional African trainers will design and develop training materials for a standardised clubfoot provider and instructor course. The courses will be piloted in Ethiopia, bringing together senior clubfoot practitioners from across the region, including orthopaedic surgeons, physiotherapists and clinical officers, to review the new instructor course materials and to enhance their training.

In addition, the project aims to improve treatment for children with neglected clubfoot, and will review the outcomes of non-surgical treatment of this condition at CURE Ethiopia Children’s Hospital over two years.

Photo: Before and after treatment for clubfoot. 

The ACT Project is a partnership between the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford, CURE Ethiopia Children’s HospitalCURE ClubfootGlobal Clubfoot Initiative (GCI)CURE International UK and local ministries of health.

Scott Reichenbach, Operations Director for CURE Clubfoot, said of the project, “We are excited and grateful for the unique opportunity to bring together clubfoot leaders from across the region with a team from Oxford, GCI and CURE to design and develop a training tool that can be replicated across sub-Saharan Africa.  This grant provides an avenue to teach the Ponseti method throughout a region, bringing us closer to a day when children born with clubfoot no longer face a life of disability.”

This project is funded by the UK Department for International Development (DFID) through a Health Partnership Scheme grant awarded by Tropical Health Education Trust, for the benefit of UK and partner country health sectors.

 

Contact: Professor Chris Lavy
Email: actproject@ndorms.ox.ac.uk
Tel: 01865 737543

© Images courtesy of CURE Clubfoot

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.